ONHS Report: HT942526ARPIDA

DoW Autism Idea Development Award

Solicitation ID: HT942526ARPIDA

Agency: DHA

Type: Grant

Deadline: 2026-10-22T00:00:00 ET

Eligibility: Yes (Unrestricted)

Funding: Approximately $2.25M to fund three awards, with a total cost cap of $750,000 per award.

Doc Type: BAA

Clearance: No

Program Manager: N/A

Last Updated: 2026-08-19 14:51

Analyzed File: HT942526ARPIDA_GG.pdf

Eligibility Reasoning

Extramural and intramural U.S. Department of War (DOW) organizations are eligible to apply, including foreign and domestic organizations, for-profit and nonprofit organizations, and public or private entities.... applications involving multidisciplinary collaborations among academia, industry, the DOW, the U.S. Department of Veterans Affairs (VA) and other federal government agencies are highly encouraged.

Note: This is an AI-generated summary...

Summary

The Department of War's (DOW) Fiscal Year 2026 (FY26) Autism Research Program (ARP) offers the Idea Development Award (Funding Opportunity Number: HT942526ARPIDA) to support innovative, high-risk/high-reward research aimed at accelerating progress and improving outcomes for Autistic individuals. The program plans to fund approximately three awards from a total allotment of $2.25 million, with a maximum of $750,000 in total costs per award over a three-year period. Key features include a strong encouragement to address one of the program's Areas of Interest, a Partnering Principal Investigator (PI) option to foster synergistic collaboration, and a prohibition on clinical trials. Eligible PIs must be at or above the Assistant Professor level. The application is a two-step process requiring a pre-application by July 27, 2026, followed by an invited full application due by October 22, 2026.

Overall Technical Areas

Preclinical Therapeutic AssessmentPreclinical ModelingIntervention Implementation ScienceTreatment Efficacy ResearchHealthcare Delivery Tool DevelopmentEnvironmental Risk Factor AnalysisLife Transition ResearchDiagnostic Method ImprovementLongitudinal Outcome AnalysisClinical Heterogeneity ResearchCo-morbidity Mechanistic StudiesSex Difference Mechanistic StudiesBiostatistics and Statistical PlanningPhenotypic Expression Analysis

Probable LBNL Areas

N/A

Focus Areas

Example Priorities:

Assessment of novel therapeutics using valid preclinical models
Create tools and strategies to increase the speed of the dissemination/implementation of evidence-based practices and interventions in community-based settings
Long-term treatment outcomes from previous clinical trials for the core symptoms of autism or to alleviate co-occurring conditions

Specific Technical Skills:

Preclinical ModelsPharmacologyBehavioral TherapyImplementation ScienceCommunity-Based ResearchClinical Trial AnalysisLongitudinal StudiesEvidence-Based PracticeTherapeutic DevelopmentOutcome Measurement

Potential PIs for this Area:

Name	Score	Organization

Example Priorities:

Determinates of diagnosis, treatment efficacy and service delivery
Development of health care provider-focused training or tools to improve health care delivery for Autistic individuals across the life span and the continuum of care (i.e., primary care, urgent/emergent care and disaster relief)
Improve diagnosis and access to services across the lifespan

Specific Technical Skills:

Diagnostic DevelopmentHealth Services ResearchMedical InformaticsProvider TrainingTreatment Efficacy AnalysisService Delivery ModelsLifespan DevelopmentHealthcare AccessibilityEmergency MedicinePrimary Care Integration

Potential PIs for this Area:

Name	Score	Organization

Example Priorities:

Mechanistic studies focused on: Heterogeneous clinical expression of autism
Mechanistic studies focused on: Underlying conditions co-occurring with autism (e.g., pain, sleep disturbances, gastrointestinal issues, inflammation, aggression, depression, anxiety, attention deficit and seizures)
Mechanistic studies focused on: Sex differences in autism (i.e., prevalence, biological mechanisms, phenotypic expression, core and comorbid syndrome expression and outcomes, developmental trajectories, diagnosis and treatment response)
Environmental risk factors

Specific Technical Skills:

NeurobiologyGeneticsImmunologyGastroenterologyPathophysiologySex Differences ResearchEnvironmental ToxicologyClinical PhenotypingComorbidity ResearchMolecular Biology

Potential PIs for this Area:

Name	Score	Organization

Example Priorities:

Factors impacting quality of life for current and former military families
Factors promoting success in key life transitions of Autistic individuals over their lifespan

Specific Technical Skills:

Quality of Life AssessmentSocial SciencesDevelopmental PsychologyFamily StudiesMilitary Family ResearchLongitudinal ResearchTransitional Support ServicesCommunity IntegrationPsychosocial InterventionsSociology

Potential PIs for this Area:

Name	Score	Organization

Potential LBNL PIs (Overall)

Note on PI Matching: These suggestions are generated through an AI-driven semantic analysis of LBNL staff profiles.

Name	Score	Organization
Jovan Tadic	0.75	ETA \| Energy Analysis \| Systems & Energy Tech Analysis · Environmental Risk Factor Analysis
Mark D. Risser	0.74	EESA \| CESD \| Earth System Sciences · Biostatistics and Statistical Planning
Stephanie Holm	0.72	ETA \| Energy Analysis \| Systems & Energy Tech Analysis · Intervention Implementation Science
Josh North	0.72	EESA \| CESD \| Earth System Sciences · Longitudinal Outcome Analysis
Adam Deutschbauer	0.72	BSA \| Env. Genomics & Sys. Biology \| Comparative and Funct Genomics · Phenotypic Expression Analysis
Jennifer Rosenbluth	0.72	· Preclinical Modeling
Jian-Hua Mao	0.72	BSA \| Biological Systems & Engineering \| Department of BioEngineering and BioMedical Sciences · Co-morbidity Mechanistic Studies
Marta Gonzalez	0.71	ETA \| Energy Analysis \| Systems & Energy Tech Analysis · Life Transition Research
Zachary Needell	0.71	ETA \| Energy Analysis \| Systems & Energy Tech Analysis · Healthcare Delivery Tool Development
Aris Polyzos	0.71	BSA \| Molecular Biophysics & Integrated Bioimaging \| Cellular & Tissue Image · Preclinical Therapeutic Assessment

Fundamental Research Exemption (FRE)

In accordance with National Security Presidential Memorandum-33 and all associated laws, all fundamental research funded by the DOW must be evaluated for affiliations with foreign entities. All applicant organizations must disclose foreign affiliations of all key personnel named on applications. Failure to disclose foreign affiliations of key personnel shall lead to withdrawal of recommendations to fund applications. Applicant organizations may be presented with an opportunity to mitigate identified risks, particularly those pertaining to influence from foreign entities specified in law. Implementation of mitigation discussions and utilization of the DOD Component Decision Matrix must decrease risk of foreign influence in accordance with the above-mentioned laws and guidance prior to award.